YCM
INBX icon

Yakira Capital Management’s Inhibrx INBX Stock Holding History

Yakira Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,118
Closed -$301K – 211
2025
Q2 		$301K Sell
21,118
-15,077
-42% -$195K 0.1% 108
2025
Q1 		$506K Hold
36,195
– – 0.19% 85
2024
Q4 		$557K Hold
36,195
– – 0.2% 90
2024
Q3 		$567K Buy
+36,195
New +$509K 0.2% 91

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Yakira Capital Management's INBX Position: Q3 2025 in Review

Yakira Capital Management sold out of Inhibrx (INBX) in Q3 2025, closing a stake of 21,118 shares — an estimated $301K sold.

Yakira Capital Management first reported a position in INBX in Q3 2024 and held it in 4 quarters. The position peaked at $567K in Q3 2024. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

  • Yakira Capital Management reported no remaining Inhibrx position as of Q3 2025 after selling out during the quarter.
  • Yakira Capital Management sold 21,118 Inhibrx shares in Q3 2025, an estimated $301K.
  • Yakira Capital Management first reported a position in Inhibrx in Q3 2024 and held it in 4 quarters.
  • Yakira Capital Management's Inhibrx position peaked at $567K in Q3 2024.
  • 102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on Yakira Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.